These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32367340)

  • 41. Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial.
    Nicholls SJ; Ray KK; Ballantyne CM; Beacham LA; Miller DL; Ruotolo G; Nissen SE; Riesmeyer JS;
    Atherosclerosis; 2017 Jun; 261():12-18. PubMed ID: 28412650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy.
    Rhee MY; Kim KJ; Kim SH; Yoon YW; Rha SW; Hong SJ; Kwak CH; Kim W; Nam CW; Park TH; Hong TJ; Park S; Ahn Y; Lee N; Jeon HK; Jeon DW; Han KR; Moon KW; Chae IH; Kim HY; Kim HS
    Clin Ther; 2019 Dec; 41(12):2571-2592. PubMed ID: 31727361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
    Elkhawad M; Rudd JH; Sarov-Blat L; Cai G; Wells R; Davies LC; Collier DJ; Marber MS; Choudhury RP; Fayad ZA; Tawakol A; Gleeson FV; Lepore JJ; Davis B; Willette RN; Wilkinson IB; Sprecher DL; Cheriyan J
    JACC Cardiovasc Imaging; 2012 Sep; 5(9):911-22. PubMed ID: 22974804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion.
    Santovito D; Marcantonio P; Mastroiacovo D; Natarelli L; Mandolini C; De Nardis V; Paganelli C; De Cesare D; Affaitati G; Giamberardino MA; Stellin L; Pinelli M; Weber C; De Blasis G; Occhiuzzi U; Bucci M; Desideri G; Cipollone F
    Int J Cardiol; 2020 Jan; 299():249-253. PubMed ID: 31409515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques.
    Meng PN; Yin DL; Lu WQ; Xu T; You W; Wu ZM; Wu XQ; Ye F
    Chin Med J (Engl); 2020 Oct; 133(20):2415-2421. PubMed ID: 32889912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study.
    Kim J; Kang D; Park H; Kang M; Choi KH; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY
    Cardiovasc Drugs Ther; 2023 Feb; 37(1):141-150. PubMed ID: 34533691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
    Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
    Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI.
    Sun C; Zheng W; Liang L; Liu Z; Sun W; Tang R
    J Interv Cardiol; 2021; 2021():2995602. PubMed ID: 34566523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.
    Soeda T; Uemura S; Okayama S; Kawakami R; Sugawara Y; Nakagawa H; Matsumoto T; Sung JH; Nishida T; Senoo A; Somekawa S; Takeda Y; Ishigami K; Kawata H; Horii M; Saito Y
    Circ J; 2011; 75(11):2621-7. PubMed ID: 21821963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
    Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW
    J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of ezetimibe combined with atorvastatin in the treatment of carotid artery plaque in patients with type 2 diabetes mellitus complicated with coronary heart disease.
    Wang J; Ai XB; Wang F; Zou YW; Li L; Yi XL
    Int Angiol; 2017 Oct; 36(5):467-473. PubMed ID: 28641407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
    Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
    Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia.
    Kim W; Yoon YE; Shin SH; Bae JW; Hong BK; Hong SJ; Sung KC; Han SH; Kim W; Rhee MY; Kim SH; Lee SE; Hyon MS; Hwang GS; Son JW; Kim JY; Kim MK; Kim SW; Park JH; Shin JH; Park CG
    Clin Ther; 2018 Jun; 40(6):993-1013. PubMed ID: 29857919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of the intensive dose of rosuvastatin 40mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2.
    Shah CP; Shah BP; Dani SI; Channa BB; Lakshmanan SS; Krishnamani NC; Mehta A; Moorthy P
    Indian Heart J; 2016; 68(6):766-771. PubMed ID: 27931543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosuvastatin dose should be case individualized: An observation from inherited hypercholesterolemia case study.
    Ayoub BM; Ashoush N; Tadros MM; El Zahar NM; Hendy MS; Mowaka S
    Pharmazie; 2020 Oct; 75(10):531-532. PubMed ID: 33305732
    [No Abstract]   [Full Text] [Related]  

  • 58. Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.
    Räber L; Koskinas KC; Yamaji K; Taniwaki M; Roffi M; Holmvang L; Garcia Garcia HM; Zanchin T; Maldonado R; Moschovitis A; Pedrazzini G; Zaugg S; Dijkstra J; Matter CM; Serruys PW; Lüscher TF; Kelbaek H; Karagiannis A; Radu MD; Windecker S
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1518-1528. PubMed ID: 30553686
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Jarr KU; Ye J; Kojima Y; Nanda V; Flores AM; Tsantilas P; Wang Y; Hosseini-Nassab N; Eberhard AV; Lotfi M; Käller M; Smith BR; Maegdefessel L; Leeper NJ
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2821-2828. PubMed ID: 33086865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.